Floating drug delivery offers several applications for drugs having poor bioavailability because of the narrow absorption window in the upper part of the gastrointestinal tract. It retains the dosage form at the site of absorption and thus enhances the bioavailability. Flurbiprofen is a newer derivative NSAID, having short half-life of 2-4 hr, which required multiple daily doses to maintain the effective drug concentration. The long oral use of FP conventional dosage forms pronounced the drug gastro-intestinal adverse effects highly. Thus, Flurbiprofen was selected as a model drug for NSAIDs which is good candidate to be developed in sustained- release formulation. Aim of present work to develop sustained released tablets of flurbiprofen us...
The present work to aim the design, fabrication and evaluation of Gemifloxacin sustained release tab...
The objective of the current study was to formulate mucoadhesive controlled release matrix tablets o...
Flurbiprofen belongs to Biopharmaceutical Classification System (BCS) class II drugs which are poorl...
In this work, a fixed-dose combination of gabapentin and flurbiprofen formulated as multilayer table...
Different formulations of floating gastroretentive tablets were prepared by using Xanthan gum, Gella...
Nanostructured lipid carriers (NLCs) are recently invented second-generation lipidic carriers. Flurb...
Sustained drug delivery systems significantly improve the therapeutic efficacy of drugs. Drug-releas...
Fast dissolving film can be defined as a dosage form, which when placed in the oral cavity. It will ...
The purpose of present research work is to develop gastro retentive formulation for Moxifloxacin usi...
Objective: Development of sustained released tablets of flurbiprofen (FP) using an alternative techn...
The main objective of this research task was to accomplish successfully development of the controlle...
Floating tablets has been accepted as a process to achieve controlled drug delivery by prolonging th...
Objective: The objective of the present study was to formulate the gastro-retentive floating tablets...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Objectives: Gastric retention systems releases drugs at the preferred absorption site optimizes deli...
The present work to aim the design, fabrication and evaluation of Gemifloxacin sustained release tab...
The objective of the current study was to formulate mucoadhesive controlled release matrix tablets o...
Flurbiprofen belongs to Biopharmaceutical Classification System (BCS) class II drugs which are poorl...
In this work, a fixed-dose combination of gabapentin and flurbiprofen formulated as multilayer table...
Different formulations of floating gastroretentive tablets were prepared by using Xanthan gum, Gella...
Nanostructured lipid carriers (NLCs) are recently invented second-generation lipidic carriers. Flurb...
Sustained drug delivery systems significantly improve the therapeutic efficacy of drugs. Drug-releas...
Fast dissolving film can be defined as a dosage form, which when placed in the oral cavity. It will ...
The purpose of present research work is to develop gastro retentive formulation for Moxifloxacin usi...
Objective: Development of sustained released tablets of flurbiprofen (FP) using an alternative techn...
The main objective of this research task was to accomplish successfully development of the controlle...
Floating tablets has been accepted as a process to achieve controlled drug delivery by prolonging th...
Objective: The objective of the present study was to formulate the gastro-retentive floating tablets...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Objectives: Gastric retention systems releases drugs at the preferred absorption site optimizes deli...
The present work to aim the design, fabrication and evaluation of Gemifloxacin sustained release tab...
The objective of the current study was to formulate mucoadhesive controlled release matrix tablets o...
Flurbiprofen belongs to Biopharmaceutical Classification System (BCS) class II drugs which are poorl...